Related Experiment Video
Updated: Mar 30, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
Single-domain antibodies for biomedical applications
Simon Krah1, Christian Schröter1, Stefan Zielonka2
1a Protein Engineering and Antibody Technologies , Merck-Serono, Merck KGaA, Darmstadt , Germany .
Single-domain antibodies, the smallest antigen-binding units, offer high affinity and specificity. These versatile molecules derived from camelids, sharks, or engineered human domains show promise in biomedical applications and clinical development.
Area of Science:
- Immunology and Biotechnology
- Molecular Biology
Background:
- Single-domain antibodies represent the smallest functional antigen-binding units.
- They can be naturally derived (camelids, sharks) or engineered (human domains).
Purpose of the Study:
- To review the characteristics and applications of single-domain antibodies.
- To highlight their potential in biomedical fields.
Main Methods:
- Review of naturally occurring and engineered antibody variable and constant domains.
- Analysis of biophysical properties such as affinity, specificity, and stability.
Main Results:
- Single-domain antibodies exhibit high affinity, specificity, and stability.
- Their small size and formatting flexibility are key advantages.
- Successful clinical development cases demonstrate their viability.
Conclusions:
- Single-domain antibodies are promising candidates for diverse biomedical applications.
- Their unique properties facilitate development and therapeutic potential.
More Related Videos
08:53In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
05:27Immunization of Alpacas Lama pacos with Protein Antigens and Production of Antigen-specific Single Domain Antibodies
Published on: January 26, 2019
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...